Clinical Trial Update: A Study of QL1706 Combined With Chemotherapy in Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating QL1706 in combination with chemotherapy for advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• QL1706

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Non-small-cell Lung Cancer | Phase 2 | Status: UNKNOWN